Walking While On Ozempic & Mounjaro: Reversing Organ Damage?

Walking is probably the most underrated intervention in all of medicine. I recommend it to nearly everyone I see.

I'm Dr. Amin Hedayat, a triple board-certified physician and clinical professor. I also read your tissue under a microscope, after something has already gone wrong. The same findings keep showing up on those slides: inflammation, stiffened blood vessels, fatty livers, kidneys that failed quietly over years. Almost none of it announced itself.

In this episode I go through six things that change inside your body when you walk daily, and then a framework for actually doing it. The liver section is the one I'd flag if you're on semaglutide or tirzepatide, or coming off one. Exercise reduces the fat inside liver cells even when the scale doesn't move, which is why walking still earns its place alongside the medication rather than being replaced by it.

What's covered:

Why chronic low-grade inflammation is the slow fire underneath most of what I see, and what regular movement does to C-reactive protein
The ten-minute after-dinner walk, and why contracting leg muscles pull glucose out of your blood through a pathway that partly bypasses insulin
Fatty liver disease, now affecting roughly a quarter to a third of adults, and one of the few places in medicine where a habit reverses damage that's already there
The step-count study that changed what I tell patients, and why the benefit levels off around 7,500 steps
Where the 10,000-step number actually came from (a 1960s Japanese pedometer campaign)
The mental health evidence, which surprised me more than anything else in this episode
A starting plan if you're currently under 3,000 steps a day

Research discussed: a 2017 meta-analysis of 83 exercise trials; a small 2013 Diabetes Care study on post-meal walking; a 2021 meta-analysis on exercise and liver fat; Stine and colleagues in the American Journal of Gastroenterology; Lee and colleagues in JAMA Internal Medicine on step counts in older women; a 2021 JAMA Network Open analysis in middle-aged adults; and a 2023 British Journal of Sports Medicine umbrella review covering more than 128,000 people.

This episode is education, not medical advice. Talk to your own physician before changing your treatment.

Stay Uninflamed.